KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Accounts Payables: 2017-2025

Historic Accounts Payables for Elanco Animal Health (ELAN) over the last 7 years, with Sep 2025 value amounting to $352.0 million.

  • Elanco Animal Health's Accounts Payables rose 35.91% to $352.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $352.0 million, marking a year-over-year increase of 35.91%. This contributed to the annual value of $296.0 million for FY2024, which is 9.63% up from last year.
  • Elanco Animal Health's Accounts Payables amounted to $352.0 million in Q3 2025, which was down 4.35% from $368.0 million recorded in Q2 2025.
  • Elanco Animal Health's Accounts Payables' 5-year high stood at $506.0 million during Q2 2021, with a 5-year trough of $259.0 million in Q3 2024.
  • Over the past 3 years, Elanco Animal Health's median Accounts Payables value was $302.0 million (recorded in 2024), while the average stood at $318.1 million.
  • As far as peak fluctuations go, Elanco Animal Health's Accounts Payables soared by 108.66% in 2021, and later tumbled by 30.77% in 2023.
  • Quarterly analysis of 5 years shows Elanco Animal Health's Accounts Payables stood at $416.0 million in 2021, then declined by 6.25% to $390.0 million in 2022, then tumbled by 30.77% to $270.0 million in 2023, then rose by 9.63% to $296.0 million in 2024, then surged by 35.91% to $352.0 million in 2025.
  • Its Accounts Payables stands at $352.0 million for Q3 2025, versus $368.0 million for Q2 2025 and $330.0 million for Q1 2025.